Caw-it, Reycel P.
HRN: 21-53-51 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/12/2022
CEFUROXIME 750MG (VIAL)
07/12/2022
07/19/2022
IVT
750mg
Q8
Fracture Close Complete Displaced D3rd Femur R
Waiting Final Action
Indication: Prophylaxis Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes